TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Needle-Free Drug Delivery Systems Market Report & Forecast 2022-2028

Global and United States Needle-Free Drug Delivery Systems Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 10 October 2022
  • Pages :105
  • Formats:
  • Report Code:SMR-7430187
OfferClick for best price

Best Price: $3480

NeedleFree Drug Delivery Systems Market Size, Share 2022


Market Analysis and Insights: Global NeedleFree Drug Delivery Systems Market

The global NeedleFree Drug Delivery Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NeedleFree Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NeedleFree Drug Delivery Systems market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NeedleFree Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NeedleFree Drug Delivery Systems market.

Global NeedleFree Drug Delivery Systems Scope and Market Size

Needle-Free Drug Delivery Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Needle-Free Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Needle-Free Drug Delivery Systems market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Jet-Based

Spring-Based

Laser-Based

Segment by Application

Hospital

Clinic

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Antares Pharma

Pharmajet

Optinose

Valeritas

Crossject

Injex Pharma

3M Pharmaceuticals

Becton Dickinson (BD)

MedImmune

Mystic Pharmaceuticals

Zogenix

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes NeedleFree Drug Delivery Systems product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of NeedleFree Drug Delivery Systems, with price, sales, revenue, and global market share of NeedleFree Drug Delivery Systems from 2019 to 2022.

Chapter 3, the NeedleFree Drug Delivery Systems competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the NeedleFree Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the NeedleFree Drug Delivery Systems market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of NeedleFree Drug Delivery Systems.

Chapter 13, 14, and 15, to describe NeedleFree Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 NeedleFree Drug Delivery Systems Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Needle-Free Drug Delivery Systems Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 105 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Needle-Free Drug Delivery Systems Product Introduction
1.2 Global Needle-Free Drug Delivery Systems Outlook 2017 VS 2022 VS 2028
1.2.1 Global Needle-Free Drug Delivery Systems Sales in US$ Million for the Year 2017-2028
1.2.2 Global Needle-Free Drug Delivery Systems Sales in Volume for the Year 2017-2028
1.3 United States Needle-Free Drug Delivery Systems Outlook 2017 VS 2022 VS 2028
1.3.1 United States Needle-Free Drug Delivery Systems Sales in US$ Million for the Year 2017-2028
1.3.2 United States Needle-Free Drug Delivery Systems Sales in Volume for the Year 2017-2028
1.4 Needle-Free Drug Delivery Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Needle-Free Drug Delivery Systems in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Needle-Free Drug Delivery Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Needle-Free Drug Delivery Systems Market Dynamics
1.5.1 Needle-Free Drug Delivery Systems Industry Trends
1.5.2 Needle-Free Drug Delivery Systems Market Drivers
1.5.3 Needle-Free Drug Delivery Systems Market Challenges
1.5.4 Needle-Free Drug Delivery Systems Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Needle-Free Drug Delivery Systems Market Segment by Type
2.1.1 Jet-Based
2.1.2 Spring-Based
2.1.3 Laser-Based
2.2 Global Needle-Free Drug Delivery Systems Market Size by Type
2.2.1 Global Needle-Free Drug Delivery Systems Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Needle-Free Drug Delivery Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Needle-Free Drug Delivery Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Needle-Free Drug Delivery Systems Market Size by Type
2.3.1 United States Needle-Free Drug Delivery Systems Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Needle-Free Drug Delivery Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Needle-Free Drug Delivery Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Needle-Free Drug Delivery Systems Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Needle-Free Drug Delivery Systems Market Size by Application
3.2.1 Global Needle-Free Drug Delivery Systems Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Needle-Free Drug Delivery Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Needle-Free Drug Delivery Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Needle-Free Drug Delivery Systems Market Size by Application
3.3.1 United States Needle-Free Drug Delivery Systems Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Needle-Free Drug Delivery Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Needle-Free Drug Delivery Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Needle-Free Drug Delivery Systems Competitor Landscape by Company
4.1 Global Needle-Free Drug Delivery Systems Market Size by Company
4.1.1 Top Global Needle-Free Drug Delivery Systems Manufacturers Ranked by Revenue (2021)
4.1.2 Global Needle-Free Drug Delivery Systems Revenue by Manufacturer (2017-2022)
4.1.3 Global Needle-Free Drug Delivery Systems Sales by Manufacturer (2017-2022)
4.1.4 Global Needle-Free Drug Delivery Systems Price by Manufacturer (2017-2022)
4.2 Global Needle-Free Drug Delivery Systems Concentration Ratio (CR)
4.2.1 Needle-Free Drug Delivery Systems Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Needle-Free Drug Delivery Systems in 2021
4.2.3 Global Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Needle-Free Drug Delivery Systems Manufacturing Base Distribution, Product Type
4.3.1 Global Needle-Free Drug Delivery Systems Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Needle-Free Drug Delivery Systems Product Type
4.3.3 Date of International Manufacturers Enter into Needle-Free Drug Delivery Systems Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Needle-Free Drug Delivery Systems Market Size by Company
4.5.1 Top Needle-Free Drug Delivery Systems Players in United States, Ranked by Revenue (2021)
4.5.2 United States Needle-Free Drug Delivery Systems Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Needle-Free Drug Delivery Systems Sales by Players (2020, 2021 & 2022)
5 Global Needle-Free Drug Delivery Systems Market Size by Region
5.1 Global Needle-Free Drug Delivery Systems Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Needle-Free Drug Delivery Systems Market Size in Volume by Region (2017-2028)
5.2.1 Global Needle-Free Drug Delivery Systems Sales in Volume by Region: 2017-2022
5.2.2 Global Needle-Free Drug Delivery Systems Sales in Volume Forecast by Region (2023-2028)
5.3 Global Needle-Free Drug Delivery Systems Market Size in Value by Region (2017-2028)
5.3.1 Global Needle-Free Drug Delivery Systems Sales in Value by Region: 2017-2022
5.3.2 Global Needle-Free Drug Delivery Systems Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Needle-Free Drug Delivery Systems Market Size YoY Growth 2017-2028
6.1.2 North America Needle-Free Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Needle-Free Drug Delivery Systems Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Needle-Free Drug Delivery Systems Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Needle-Free Drug Delivery Systems Market Size YoY Growth 2017-2028
6.3.2 Europe Needle-Free Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Needle-Free Drug Delivery Systems Market Size YoY Growth 2017-2028
6.4.2 Latin America Needle-Free Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Needle-Free Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Antares Pharma
7.1.1 Antares Pharma Corporation Information
7.1.2 Antares Pharma Description and Business Overview
7.1.3 Antares Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Antares Pharma Needle-Free Drug Delivery Systems Products Offered
7.1.5 Antares Pharma Recent Development
7.2 Pharmajet
7.2.1 Pharmajet Corporation Information
7.2.2 Pharmajet Description and Business Overview
7.2.3 Pharmajet Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pharmajet Needle-Free Drug Delivery Systems Products Offered
7.2.5 Pharmajet Recent Development
7.3 Optinose
7.3.1 Optinose Corporation Information
7.3.2 Optinose Description and Business Overview
7.3.3 Optinose Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Optinose Needle-Free Drug Delivery Systems Products Offered
7.3.5 Optinose Recent Development
7.4 Valeritas
7.4.1 Valeritas Corporation Information
7.4.2 Valeritas Description and Business Overview
7.4.3 Valeritas Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Valeritas Needle-Free Drug Delivery Systems Products Offered
7.4.5 Valeritas Recent Development
7.5 Crossject
7.5.1 Crossject Corporation Information
7.5.2 Crossject Description and Business Overview
7.5.3 Crossject Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Crossject Needle-Free Drug Delivery Systems Products Offered
7.5.5 Crossject Recent Development
7.6 Injex Pharma
7.6.1 Injex Pharma Corporation Information
7.6.2 Injex Pharma Description and Business Overview
7.6.3 Injex Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Injex Pharma Needle-Free Drug Delivery Systems Products Offered
7.6.5 Injex Pharma Recent Development
7.7 3M Pharmaceuticals
7.7.1 3M Pharmaceuticals Corporation Information
7.7.2 3M Pharmaceuticals Description and Business Overview
7.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Products Offered
7.7.5 3M Pharmaceuticals Recent Development
7.8 Becton Dickinson (BD)
7.8.1 Becton Dickinson (BD) Corporation Information
7.8.2 Becton Dickinson (BD) Description and Business Overview
7.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Products Offered
7.8.5 Becton Dickinson (BD) Recent Development
7.9 MedImmune
7.9.1 MedImmune Corporation Information
7.9.2 MedImmune Description and Business Overview
7.9.3 MedImmune Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.9.4 MedImmune Needle-Free Drug Delivery Systems Products Offered
7.9.5 MedImmune Recent Development
7.10 Mystic Pharmaceuticals
7.10.1 Mystic Pharmaceuticals Corporation Information
7.10.2 Mystic Pharmaceuticals Description and Business Overview
7.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Products Offered
7.10.5 Mystic Pharmaceuticals Recent Development
7.11 Zogenix
7.11.1 Zogenix Corporation Information
7.11.2 Zogenix Description and Business Overview
7.11.3 Zogenix Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Zogenix Needle-Free Drug Delivery Systems Products Offered
7.11.5 Zogenix Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Needle-Free Drug Delivery Systems Industry Chain Analysis
8.2 Needle-Free Drug Delivery Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Needle-Free Drug Delivery Systems Distributors
8.3 Needle-Free Drug Delivery Systems Production Mode & Process
8.4 Needle-Free Drug Delivery Systems Sales and Marketing
8.4.1 Needle-Free Drug Delivery Systems Sales Channels
8.4.2 Needle-Free Drug Delivery Systems Distributors
8.5 Needle-Free Drug Delivery Systems Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Needle-Free Drug Delivery Systems CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Needle-Free Drug Delivery Systems Market Trends
Table 3. Needle-Free Drug Delivery Systems Market Drivers
Table 4. Needle-Free Drug Delivery Systems Market Challenges
Table 5. Needle-Free Drug Delivery Systems Market Restraints
Table 6. Global Needle-Free Drug Delivery Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Needle-Free Drug Delivery Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Needle-Free Drug Delivery Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Needle-Free Drug Delivery Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Needle-Free Drug Delivery Systems Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Needle-Free Drug Delivery Systems Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturer, 2017-2022
Table 13. Global Needle-Free Drug Delivery Systems Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Needle-Free Drug Delivery Systems Sales Share by Manufacturer, 2017-2022
Table 15. Global Needle-Free Drug Delivery Systems Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Needle-Free Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Needle-Free Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Drug Delivery Systems as of 2021)
Table 18. Top Players of Needle-Free Drug Delivery Systems in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Needle-Free Drug Delivery Systems Product Type
Table 20. Date of International Manufacturers Enter into Needle-Free Drug Delivery Systems Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Needle-Free Drug Delivery Systems Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Needle-Free Drug Delivery Systems Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Needle-Free Drug Delivery Systems Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Needle-Free Drug Delivery Systems Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Needle-Free Drug Delivery Systems Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Needle-Free Drug Delivery Systems Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Needle-Free Drug Delivery Systems Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Needle-Free Drug Delivery Systems Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Needle-Free Drug Delivery Systems Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Needle-Free Drug Delivery Systems Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Needle-Free Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Needle-Free Drug Delivery Systems Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Needle-Free Drug Delivery Systems Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Needle-Free Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Needle-Free Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Needle-Free Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Needle-Free Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Antares Pharma Corporation Information
Table 43. Antares Pharma Description and Business Overview
Table 44. Antares Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Antares Pharma Needle-Free Drug Delivery Systems Product
Table 46. Antares Pharma Recent Development
Table 47. Pharmajet Corporation Information
Table 48. Pharmajet Description and Business Overview
Table 49. Pharmajet Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Pharmajet Product
Table 51. Pharmajet Recent Development
Table 52. Optinose Corporation Information
Table 53. Optinose Description and Business Overview
Table 54. Optinose Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Optinose Product
Table 56. Optinose Recent Development
Table 57. Valeritas Corporation Information
Table 58. Valeritas Description and Business Overview
Table 59. Valeritas Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Valeritas Product
Table 61. Valeritas Recent Development
Table 62. Crossject Corporation Information
Table 63. Crossject Description and Business Overview
Table 64. Crossject Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Crossject Product
Table 66. Crossject Recent Development
Table 67. Injex Pharma Corporation Information
Table 68. Injex Pharma Description and Business Overview
Table 69. Injex Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Injex Pharma Product
Table 71. Injex Pharma Recent Development
Table 72. 3M Pharmaceuticals Corporation Information
Table 73. 3M Pharmaceuticals Description and Business Overview
Table 74. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. 3M Pharmaceuticals Product
Table 76. 3M Pharmaceuticals Recent Development
Table 77. Becton Dickinson (BD) Corporation Information
Table 78. Becton Dickinson (BD) Description and Business Overview
Table 79. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Becton Dickinson (BD) Product
Table 81. Becton Dickinson (BD) Recent Development
Table 82. MedImmune Corporation Information
Table 83. MedImmune Description and Business Overview
Table 84. MedImmune Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. MedImmune Product
Table 86. MedImmune Recent Development
Table 87. Mystic Pharmaceuticals Corporation Information
Table 88. Mystic Pharmaceuticals Description and Business Overview
Table 89. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Mystic Pharmaceuticals Product
Table 91. Mystic Pharmaceuticals Recent Development
Table 92. Zogenix Corporation Information
Table 93. Zogenix Description and Business Overview
Table 94. Zogenix Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Zogenix Product
Table 96. Zogenix Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Needle-Free Drug Delivery Systems Customers List
Table 100. Needle-Free Drug Delivery Systems Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Needle-Free Drug Delivery Systems Product Picture
Figure 2. Global Needle-Free Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Needle-Free Drug Delivery Systems Market Size 2017-2028 (US$ Million)
Figure 4. Global Needle-Free Drug Delivery Systems Sales 2017-2028 (K Units)
Figure 5. United States Needle-Free Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Needle-Free Drug Delivery Systems Market Size 2017-2028 (US$ Million)
Figure 7. United States Needle-Free Drug Delivery Systems Sales 2017-2028 (K Units)
Figure 8. United States Needle-Free Drug Delivery Systems Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Needle-Free Drug Delivery Systems Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Needle-Free Drug Delivery Systems Report Years Considered
Figure 11. Product Picture of Jet-Based
Figure 12. Product Picture of Spring-Based
Figure 13. Product Picture of Laser-Based
Figure 14. Global Needle-Free Drug Delivery Systems Market Share by Type in 2022 & 2028
Figure 15. Global Needle-Free Drug Delivery Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Needle-Free Drug Delivery Systems Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Needle-Free Drug Delivery Systems Sales by Type (2017-2028) & (K Units)
Figure 18. Global Needle-Free Drug Delivery Systems Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Needle-Free Drug Delivery Systems Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Needle-Free Drug Delivery Systems Market Share by Type in 2022 & 2028
Figure 21. United States Needle-Free Drug Delivery Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Needle-Free Drug Delivery Systems Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Needle-Free Drug Delivery Systems Sales by Type (2017-2028) & (K Units)
Figure 24. United States Needle-Free Drug Delivery Systems Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Needle-Free Drug Delivery Systems Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Hospital
Figure 27. Product Picture of Clinic
Figure 28. Product Picture of Others
Figure 29. Global Needle-Free Drug Delivery Systems Market Share by Application in 2022 & 2028
Figure 30. Global Needle-Free Drug Delivery Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Needle-Free Drug Delivery Systems Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Needle-Free Drug Delivery Systems Sales by Application (2017-2028) & (K Units)
Figure 33. Global Needle-Free Drug Delivery Systems Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Needle-Free Drug Delivery Systems Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Needle-Free Drug Delivery Systems Market Share by Application in 2022 & 2028
Figure 36. United States Needle-Free Drug Delivery Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Needle-Free Drug Delivery Systems Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Needle-Free Drug Delivery Systems Sales by Application (2017-2028) & (K Units)
Figure 39. United States Needle-Free Drug Delivery Systems Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Needle-Free Drug Delivery Systems Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Needle-Free Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Needle-Free Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Needle-Free Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Needle-Free Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Needle-Free Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Needle-Free Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Needle-Free Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Needle-Free Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Needle-Free Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Needle-Free Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Needle-Free Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Needle-Free Drug Delivery Systems Value Chain
Figure 75. Needle-Free Drug Delivery Systems Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount